|
Mr. Hennessey served as President and Chief Executive Officer of Penwest during the interim period from February 2005 to December 2005. From March 1993 to January 2001, he was the Chairman, President and CEO of Genome Therapeutics Corporation (now known as Oscient Pharmaceuticals). Previously, Mr. Hennessey was an independent consultant of Hennessey & Associates, Ltd. Prior to that, Mr. Hennessey was Senior Vice President of Corporate Development for Sterling Drug, Inc. and also served in various executive assignments at Merck & Co., Inc., SmithKline Beecham PLC, and Abbott Laboratories. Mr. Hennessey is a director of Oscient Pharmaceuticals and Repligen Corporation. Mr. Hennessey holds an M.A. and an A.B. from the University of Connecticut. | 